# Tansna Therapeutics, Inc. — Form D

Tansna Therapeutics, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-25. The offering totals $850K. Industry: Biotechnology.

## Offering

- Filed: 2013-09-25
- Form: D
- Accession: 0001587426-13-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $850K
- Remaining: $850K
- Minimum investment: $50K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-203528

## Issuer

- Name: Tansna Therapeutics, Inc.
- CIK: 0001587426
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 4320 FOREST PARK AVENUE, ST. LOUIS, MO, 63108
- Phone: 8609382315

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Max Baker | Director | Seattle, WA |
| Charles Bolten | Director | St. Louis, MO |
| Rajesh Devraj | Director | St. Louis, MO |
| Kathleen Beckmann | Executive Officer | St. Louis, MO |
| George Capps | Executive Officer | St. Louis, MO |
| Robert Karr | Executive Officer | St. Louis, MO |
| ALAN MACINNES | Executive Officer | WILDWOOD, MO |

## More

- [CIK 1587426 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1587426&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001587426-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.